Guido Eibl

31 papers and 1.4k indexed citations i.

About

Guido Eibl is a scholar working on Molecular Biology, Pharmacology and Oncology. According to data from OpenAlex, Guido Eibl has authored 31 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Biology, 13 papers in Pharmacology and 9 papers in Oncology. Recurrent topics in Guido Eibl’s work include Pancreatic and Hepatic Oncology Research (7 papers), Flavonoids in Medical Research (6 papers) and Cancer, Lipids, and Metabolism (4 papers). Guido Eibl is often cited by papers focused on Pancreatic and Hepatic Oncology Research (7 papers), Flavonoids in Medical Research (6 papers) and Cancer, Lipids, and Metabolism (4 papers). Guido Eibl collaborates with scholars based in United States, Switzerland and Japan. Guido Eibl's co-authors include O. Joe Hines, Howard A. Reber, Eliane Angst, Anna S. Gukovskaya, Aune Moro, Vay Liang W. Go, Xuyang Lu, David W. Dawson, Kathleen M. Hertzer and Graham Donald and has published in prestigious journals such as Journal of Biological Chemistry, Gastroenterology and Cancer Research.

In The Last Decade

Co-authorship network of co-authors of Guido Eibl i

Fields of papers citing papers by Guido Eibl

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Guido Eibl. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Guido Eibl. The network helps show where Guido Eibl may publish in the future.

Countries citing papers authored by Guido Eibl

Since Specialization
Citations

This map shows the geographic impact of Guido Eibl's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Guido Eibl with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Guido Eibl more than expected).

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar’s output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2025